NTQ5082 capsule
NTQ5082-24102
Phase 1 small_molecule active
Quick answer
NTQ5082 capsule for Complement-mediated Hemolytic Diseases is a Phase 1 program (small_molecule) at Nanjing Chia-tai Tianqing Pharmaceutical with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Nanjing Chia-tai Tianqing Pharmaceutical
- Indication
- Complement-mediated Hemolytic Diseases
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active